PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
877.13%
Revenue growth of 877.13% vs. zero growth in Healthcare. Walter Schloss might still want to see if it can translate into profits.
177.09%
Gross profit growth of 177.09% while Healthcare median is zero. Walter Schloss might see a slight advantage that could be built upon.
-20.78%
Negative EBIT growth while Healthcare median is 0.00%. Seth Klarman would check if external or internal factors caused the decline.
-20.78%
Negative operating income growth while Healthcare median is 0.00%. Seth Klarman would check if structural or cyclical issues are at play.
83.07%
Net income growth of 83.07% while Healthcare median is zero. Walter Schloss might see potential if moderate gains can keep rising.
83.25%
EPS growth of 83.25% while Healthcare median is zero. Walter Schloss might see a slight edge that could compound over time.
83.25%
Diluted EPS growth of 83.25% while Healthcare median is zero. Walter Schloss might see a slight edge that could improve over time.
0.59%
Share change of 0.59% while Healthcare median is zero. Walter Schloss would see if the modest difference matters long-term.
0.59%
Diluted share change of 0.59% while Healthcare median is zero. Walter Schloss might see a slight difference in equity issuance policy.
No Data
No Data available this quarter, please select a different quarter.
54.66%
OCF growth of 54.66% while Healthcare is zero. Walter Schloss might see a modest positive difference, which can compound over time.
39.94%
FCF growth of 39.94% while Healthcare median is zero. Walter Schloss might see a slight edge that could compound over time.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1466.81%
Negative 10Y OCF/share CAGR while Healthcare median is 0.00%. Seth Klarman would suspect the firm is failing to keep pace with industry peers.
-1466.81%
Negative 5Y OCF/share CAGR while Healthcare median is 0.00%. Seth Klarman might see a firm-specific issue if peers still expand cash flow.
-1466.81%
Negative 3Y OCF/share CAGR while Healthcare median is 0.00%. Seth Klarman would check whether it’s cyclical or a firm-specific problem.
-86.27%
Negative 10Y net income/share CAGR vs. Healthcare median of 0.00%. Seth Klarman might see a fundamental problem if peers maintain growth.
-86.27%
Negative 5Y CAGR while Healthcare median is 0.00%. Seth Klarman might see a specific weakness if peers maintain profitable expansions.
-86.27%
Negative 3Y CAGR while Healthcare median is 0.00%. Seth Klarman might see a pressing concern if the rest of the sector is stable or growing.
147.79%
Equity/share CAGR of 147.79% while Healthcare median is zero. Walter Schloss might see a modest advantage in net worth accumulation that could matter long term.
147.79%
5Y equity/share CAGR > 1.5x Healthcare median of 8.75%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.
147.79%
3Y equity/share CAGR > 1.5x Healthcare median of 12.68%. Joel Greenblatt sees strong short-term returns on equity fueling net worth growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
76.22%
AR growth of 76.22% while Healthcare median is zero. Walter Schloss checks if the difference points to new credit strategy or stronger sales push.
92.35%
Inventory growth of 92.35% while Healthcare median is zero. Walter Schloss checks if we’re preparing for a sales push or risking overstock.
-0.72%
Assets shrink while Healthcare median grows. Seth Klarman might see a strategic refocus or potential missed expansion if demand is present.
-2.67%
Negative BV/share change while Healthcare median is 0.00%. Seth Klarman sees a firm-specific weakness if peers accumulate net worth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-68.21%
SG&A decline while Healthcare grows. Seth Klarman sees potential cost advantage or a risk if it hurts future growth.